1. Home
  2. Browse Decisions
  3. F.3d
  4. 747 F.3d
  5. 747 F.3d 501 (2014)
 

BOEHM v. ELI LILLY & CO.

No. 13-1350.

747 F.3d 501 (2014)

Timothy BOEHM, Plaintiff-Appellant v. ELI LILLY & COMPANY, Defendant-Appellee.

United States Court of Appeals, Eighth Circuit.

Filed: March 10, 2014.

Rehearing and Rehearing En Banc Denied April 15, 2014.

Attorney(s) appearing for the Case

Sidney W. Jackson, III , argued, Mobile, AL ( Richard N. Turbeville , Little Rock, AR, on the brief), for Plaintiff-Appellant.

Andrew E. Kantra , argued, Philadelphia, PA ( Lyn P. Pruitt , Little Rock, AR., Nina M. Gussack , Philadelphia, PA, on the brief), for Defendant-Appellee.

Before LOKEN, COLLOTON, and BENTON, Circuit Judges.

LOKEN, Circuit Judge.

Zyprexa (active ingredient olanzapine) is an "atypical" or "second generation" antipsychotic drug manufactured and sold by Eli Lilly & Company ("Lilly"). Timothy Boehm's doctors prescribed Zyprexa to treat his bipolar disorder from January 2003 until March 2007, when he developed symptoms later diagnosed as tardive dyskinesia ("TD") — an involuntary movement disorder long recognized as a side effect of antipsychotic drugs. Boehm brought...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases